Shuttle Pharmaceuticals Holdings, Inc.
- SHPH
- NASDAQ
- Drug Manufacturers - Specialty & Generic
- Radiosensitizing Drugs
- Oncology Therapeutics
$4.67
Today −1.00%Quote Oct 20, 2026, 02:02 PM UTC
+35.24%over the last month
Max drawdown −15.3%From 1-month high −15.3%3 months +40.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Shuttle Pharmaceuticals
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Employees
2
Founded
2012
Market value
$22.3M
Quote Oct 20
Floor
$4.35
7.0% below price
Resistance
$4.71
0.9% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about SHPHPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free